Magnacef (Cefixime) is a semi-synthetic third generation cephalosporin which has a bactericidal action against most strains of organisms including penicillin’s producing strains. Magnacef has an average peak plasma concentrations occurring within 4 hrs after oral administration with a half-life of 3-4 hrs.
Magnacef is indicated for the treatment of:
- Upper respiratory tract infections: Otitis media, pharyngitis and tonsillitis.
- Lower respiratory tract infections: Acute bronchitis and acute exacerbation of chronic bronchitis.
- Uro-genital infections and sexually transmitted diseases such as gonorrhea.
Magnacef – 200 Capsules: Each capsule contains Cefixime Trihydrate USP equivalent to 200 mg Cefixime. Blister packs of 8 capsules.
Magnacef – 400 Capsules: Each capsule contains Cefixime Trihydrate USP equivalent to 400 mg Cefixime. Blister packs of 6, 5 capsules.
Magnacef for Oral Suspension: Each 5 ml of reconstituted suspension contains Cefixime Trihydrate USP equivalent to 100 mg Cefixime. Bottles of 30 & 60 ml suspension.